Cryptorchidism as a potential source of misinterpretation in ¹⁸FDG-PET imaging in restaging lymphoma patients

Biomed Pharmacother. 2013 Jul;67(6):533-8. doi: 10.1016/j.biopha.2013.04.011. Epub 2013 May 7.

Abstract

Purpose: The estimated prevalence of cryptorchidism in young males is close to 2%. In oncological PET/CT studies, it might be difficult to recognize false-positive ¹⁸FDG uptake due to an ectopic testis.

Materials and methods: In this pilot study, we report on three patients with lymphoma referred for assessment of response to treatment and in whom cryptorchidism was not known at the time of ¹⁸FDG-PET/CT imaging.

Results: In each of these patients, moderate ¹⁸FDG uptake corresponding to an ovoid mass in the inguinal canal was (or could has been) misinterpreted as a lymphoma-involved inguinal lymph node. Clues to avoid misinterpretation are discussed.

Conclusion: Moderate ¹⁸FDG uptake in ectopic testes represents a potential source of false-positive at initial staging or evaluation of therapeutic response of lymphomas and other malignancies that needs to be recognized.

Keywords: Cryptorchidism; FDG-PET; Lymphoma; Response evaluation; Retractile testis; Undescended testis.

MeSH terms

  • Adult
  • Cryptorchidism / diagnosis*
  • Cryptorchidism / diagnostic imaging*
  • Cryptorchidism / pathology
  • Fluorodeoxyglucose F18 / administration & dosage*
  • Humans
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / pathology
  • Lymphoma / diagnostic imaging*
  • Lymphoma / pathology*
  • Male
  • Multimodal Imaging / methods
  • Neoplasm Staging
  • Pilot Projects
  • Positron-Emission Tomography / methods
  • Prognosis
  • Radiopharmaceuticals / administration & dosage
  • Tomography, X-Ray Computed / methods
  • Young Adult

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18